Lv11
24 积分 2024-11-14 加入
Phase II Study of Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab as a Later-line Therapy for Patients with Metastatic Colorectal Cancer (mCRC): a prospective single-center explorative study
19分钟前
待确认
Irinotecan with trifluridine/tipiracil and bevacizumab for second-line metastatic colorectal cancer: a phase II multicenter study
23分钟前
已完结
Catabolism of extracellular glutathione supplies cysteine to support tumours
2个月前
已完结
Fruquintinib with programmed cell death ‐ 1 inhibitors versus triflueridine ‐ tipiracil ‐ 102 with bevacizumab in late‐line mCRC : A retrospective cohort study based on propensity score matching
7个月前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
7个月前
已完结
Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study
7个月前
已完结
MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1
8个月前
已完结
MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1
8个月前
已完结
MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1
8个月前
已完结